US: ATGGF - Actinogen Medical Limited

Yield per half year: +66.67%
Dividend yield: 0.00%

Share chart Actinogen Medical Limited

Extended chart Simple chart
Financial Markets by TradingView

About Actinogen Medical Limited

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials, that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015.

more details
Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета aud
Сайт https://actinogen.com.au
Цена ао 0.025
Change price per day: 0% (0.025)
Change price per week: 0% (0.025)
Change price per month: 0% (0.025)
Change price per 3 month: +25% (0.02)
Change price per half year: +66.67% (0.015)
Change price per year: +66.67% (0.015)
Change price per 3 year: +4.17% (0.024)
Change price per 5 year: -28.57% (0.035)
Change price per year to date: +25% (0.02)
All parameters

Underestimation

Title Value Grade
P/S 4.93 3
P/BV 2.49 6
P/E 0 0
EV/EBITDA -3.08 0
Total: 4.88

Efficiency

Title Value Grade
ROA, % -71.44 0
ROE, % -78.81 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0247 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 182.43 10
Yield Ebitda, % 164.31 10
Yield EPS, % 122.2 10
Total: 10
More

Head Job title Payment Year of birth
Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D. MD, CEO & Director 1959 (66 years)
Mr. William Edward Souter BCom, IPAA, LLB (Adel) Chief Financial Officer
Dr. Dana C. Hilt M.D. Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board 1953 (72 years)
Mr. Michael Roberts Head of Investor Relations & Corporate Communications
Prof. Paul Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D. Head of Clinical Pharmacology & Lead Physician and Depression
Dr. Fujun Li Ph.D. Head of Manufacturing
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. Company Secretary 1963 (62 years)

Address: Australia, Sydney, 109 Pitt Street - open in Google maps, open in Yandex maps
Website: https://actinogen.com.au